# Luxonus

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/luxonus

- Industry: Medical Devices & Equipment
- Headquarters: Kawasaki, Japan
- Website: www.luxonus.jp
- Total disclosed funding: $12M
- Latest round: Series C (Jul 31, 2023)
- Investors on record: 13

## About

Founded in 2018 and based in Kanagawa, Japan, Luxonus Inc. develops image diagnostic devices that can take ultra-high-resolution 3D images safely and easily without exposure by using optical ultrasonic imaging technology that combines light and ultrasonic waves. 

With the new technology developed by the company, it's possible to obtain information on the morphology and function of blood vessels and lymphatic vessels, which enables a comprehensive understanding of the onset of disease, the healing process, and pre and post-illness health conditions. 

Photoacoustic imaging is a technology that captures ultrasonic waves generated when a living body is irradiated with pulsed light with a special sensor and receives data for computer analysis. New diagnostic imaging equipment using PAI is non-invasive (using contrast medium) compared to existing imaging technologies. In addition, hemoglobin oxygen saturation and lymphatic vessels can be visualized, which is expected to be used for pre-operative planning and verification of medication effects. 

Luxonus Inc. was established in 2018. In August 2020, the company received a license from Kanagawa Prefecture for the manufacture and sale of Type 2 medical devices. Luxonus will sell optical ultrasonic 3D imaging equipment for animal experiments in the latter half of 2021.

## Funding rounds

- Series C, Jul 31, 2023, $1.6M — IT-Farm Corporation, MIRAIDOOR, KSP, Kyoto University Innovation Capital
- Series B, May 20, 2022, $0.9M — 360ip, Miraisozo Investments
- Series B, Sep 10, 2021, $3.9M — Mitsubishi UFJ Capital, SMBC Venture Capital, MIRAIDOOR, Keio Innovation Initiative
- Series A, Nov 21, 2019, $5.5M — Mitsubishi UFJ Capital, Yokohama Capital, KSP, Keio Innovation Initiative, Kyoto University Innovation Capital, OKB Capital, Japanese Organization for Medical Device Development, Inc., Shibaura Institute of Technology
- Seed, Mar 8, 2019 — Keio Innovation Initiative, Kyoto University Innovation Capital, Japanese Organization for Medical Device Development, Inc.

## Investors

- Keio Innovation Initiative (https://capitalatlas.ai/funds/keio-innovation-initiative) — Seed, Series A, Series B
- Kyoto University Innovation Capital (https://capitalatlas.ai/funds/kyoto-university-innovation-capital) — Seed, Series A, Series C
- Japanese Organization for Medical Device Development, Inc. — Seed, Series A
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series A, Series B
- Yokohama Capital (https://capitalatlas.ai/funds/yokohama-capital) — Series A
- KSP (https://capitalatlas.ai/funds/ksp) — Series A, Series C
- OKB Capital (https://capitalatlas.ai/funds/okb-capital) — Series A
- Shibaura Institute of Technology — Series A
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series B
- MIRAIDOOR (https://capitalatlas.ai/funds/miraidoor) — Series B, Series C
- 360ip (https://capitalatlas.ai/funds/360ip) — Series B
- Miraisozo Investments (https://capitalatlas.ai/funds/miraisozo-investments) — Series B
- IT-Farm Corporation (https://capitalatlas.ai/funds/it-farm-corporation) — Series C